Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness.

The Lancet Infectious Diseases
John F Brundage

Abstract

It is commonly believed that the clinical and epidemiological characteristics of the next influenza pandemic will mimic those of the 1918 pandemic. Determinative beliefs regarding the 1918 pandemic include that infections were expressed as primary viral pneumonias and/or acute respiratory distress syndrome, that pandemic-related deaths were the end states of the natural progression of disease caused by the pandemic strain, and that bacterial superinfections caused relatively fewer deaths in 1918 than in subsequent pandemics. In turn, response plans are focused on developing and/or increasing inventories of a strain-specific vaccine, antivirals, intensive care beds, mechanical ventilators, and so on. Yet, there is strong and consistent evidence of epidemiologically and clinically important interactions between influenza and secondary bacterial respiratory pathogens, including during the 1918 pandemic. Countermeasures (eg, vaccination against pneumococcal and meningococcal disease before a pandemic; mass uses of antibiotic(s) with broad spectrums of activity against common bacterial respiratory pathogens during local epidemics) designed to prevent or mitigate the effects of influenza-bacterial interactions should be major focuses...Continue Reading

References

Feb 1, 1976·Southern Medical Journal·P A MackowiakJ Thomason
Sep 1, 1992·The Journal of Infectious Diseases·B HubertS Richardson
Aug 1, 1992·The Journal of Infectious Diseases·J D GunzenhauserR N Miller
Aug 31, 1991·Lancet·K A CartwrightS R Palmer
Nov 2, 1991·Lancet·S Reilly, P N Gaunt
Sep 1, 1990·Infection and Immunity·C L Nickerson, G J Jakab
Nov 1, 1986·Reviews of Infectious Diseases·B T Rouse, D W Horohov
Jan 1, 1988·Advances in Virus Research·L A BabiukH B Ohmann
Feb 27, 1987·JAMA : the Journal of the American Medical Association·K L MacDonaldP M Schlievert
Feb 27, 1987·JAMA : the Journal of the American Medical Association·S J Sperber, J B Francis
Sep 28, 1967·The New England Journal of Medicine·K P Nichol, J D Cherry
Jul 6, 1972·The New England Journal of Medicine·L S YoungJ V Bennett
Dec 7, 1970·JAMA : the Journal of the American Medical Association·M I LindsayA L Brown
Jan 1, 1984·Annual Review of Medicine·E L Mills
Jan 1, 1982·Reviews of Infectious Diseases·J M Griffiss
Mar 15, 1996·Annals of Internal Medicine·R J SherertzJ M Gwaltney
Jan 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P E KimC E Wright
Oct 29, 2000·The Pediatric Infectious Disease Journal·D A Goldmann
Aug 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P MakrasD Hatzigeorgiou
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G C GrayM R Wallace
Mar 5, 2002·Bulletin of the History of Medicine·Niall P A S Johnson, Juergen Mueller
Mar 21, 2002·The Lancet Infectious Diseases·J S OxfordN P A S Johnson
Nov 30, 2002·Medical Microbiology and Immunology·R FockA Wirtz
Jul 26, 2003·American Journal of Preventive Medicine·Nancy F CrumKenneth C Earhart
Feb 1, 1959·A.M.A. Archives of Internal Medicine·R G PETERSDORFW S ALBRINK
Aug 1, 1960·American Journal of Diseases of Children·H F EICHENWALDL A FASSO
Feb 28, 2004·Lancet·J S M PeirisY Guan
Mar 20, 2004·Emerging Infectious Diseases·Tze-wai WongUNKNOWN Outbreak Study Group
Jun 29, 2004·The Lancet Infectious Diseases·Daniel R FeikinEdward N Janoff
Jul 13, 2004·Nature Medicine·Shabir A MadhiUNKNOWN Vaccine Trialist Group
Dec 4, 2004·Nature Medicine·J S M PeirisK Y Yuen
Dec 17, 2004·Nature·Christina E MillsMarc Lipsitch
Mar 11, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stefano BassettiRobert J Sherertz
Apr 20, 2005·Emerging Infectious Diseases·Stefano BassettiRobert J Sherertz
May 6, 2005·The New England Journal of Medicine·Michael T Osterholm
May 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·David J EckerSteven A Hofstadler
Jun 18, 2005·The Journal of Infectious Diseases·Ville T PeltolaJonathan A McCullers
Sep 21, 2005·Annals of Internal Medicine·John G Bartlett, Frederick G Hayden
Sep 30, 2005·The New England Journal of Medicine·John H BeigelUNKNOWN Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5
Oct 7, 2005·Nature·Jeffery K TaubenbergerThomas G Fanning
Oct 8, 2005·Science·Terrence M TumpeyAdolfo García-Sastre

❮ Previous
Next ❯

Citations

Mar 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M JohnS O'Leary
Nov 19, 2013·Respiratory Investigation·Arata AzumaUNKNOWN Influenza Practical Treatment Workshop on New Targets of Macrolides
Jul 18, 2012·Epidemiology and Infection·S R BenoitS Jain
Jan 30, 2008·The Journal of Experimental Medicine·Arnaud DidierlaurentTracy Hussell
Nov 17, 2007·The Journal of Infectious Diseases·John F Brundage, G Dennis Shanks
Jan 19, 2010·The Journal of Infectious Diseases·Mei-Ho LeeFranklin D Lowy
Oct 14, 2009·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Sandro K CintiRobert A Winfield
Oct 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vivek CharuCécile Viboud
Jun 21, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cheryl CohenCecile Viboud
Dec 14, 2011·The Journal of Infectious Diseases·Daniel M WeinbergerCécile Viboud
Dec 14, 2011·The Journal of Infectious Diseases·Carlos G Grijalva, Marie R Griffin
Dec 12, 2012·The Journal of Infectious Diseases·Cécile ViboudJeffery K Taubenberger
Jan 11, 2013·The Journal of Infectious Diseases·Katherine E Fleming-DutraMatthew R Moore
May 11, 2013·The Journal of Infectious Diseases·Ann R FalseyEdward E Walsh
Dec 16, 2009·The Pediatric Infectious Disease Journal·Hanna NohynekCarlos G Grijalva
Feb 6, 2010·The Pediatric Infectious Disease Journal·Hannah C MooreUNKNOWN Kalgoorlie Otitis Media Research Project Team
Jan 23, 2013·The Pediatric Infectious Disease Journal·Angela DomínguezUNKNOWN CIBERESP Cases and Controls in Pandemic Influenza Working Group Spain
Aug 9, 2011·Pediatric Emergency Care·Erica Y Chung, Vincent W Chiang
Jun 28, 2013·Science Translational Medicine·Sourya ShresthaPejman Rohani
Jul 8, 2011·Clinical Microbiology Reviews·Barry B Mook-KanamoriDiederik van de Beek
Jan 11, 2013·Mediators of Inflammation·Emily Gwyer Findlay, Tracy Hussell
Jan 22, 2008·American Journal of Respiratory Cell and Molecular Biology·Zhaoxi WangDavid C Christiani
Feb 2, 2013·BMC Infectious Diseases·John J McKennaUNKNOWN 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team
Feb 2, 2013·Clinical and Translational Medicine·Paul King
Dec 1, 2011·Critical Care : the Official Journal of the Critical Care Forum·Ignacio Martin-LoechesUNKNOWN H1N1 SEMICYUC/REIPI/CIBERES Working group
Jan 13, 2009·PloS One·Michael J TuvimBrian E Gilbert
May 23, 2009·American Journal of Public Health·Richard A Hobday, John W Cason

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.